about
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Glucose effectiveness in obese children: relation to degree of obesity and dysglycemia.Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndromePrediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peers.Leptin levels among prepubertal children with Down syndrome compared with their siblingsA Social Media Peer Group Intervention for Mothers to Prevent Obesity and Promote Healthy Growth from Infancy: Development and Pilot Trial.Sex differences in the associations of visceral adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis in obese adolescentsNutrition in Children and Adolescents.Body composition estimation using skinfolds in children with and without health conditions affecting growth and body composition.Mothers' and Clinicians' Priorities for Obesity Prevention Among Black, High-Risk Infants.Familial leucine-sensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor.Caregiver-Reported Quality of Life in Youth with Down Syndrome.Glycemic control in youth with type 2 diabetes declines as early as two years after diagnosis.Vitamin D3 supplementation to preserve pancreatic β-cell function in newly diagnosed type 1 diabetic patientsHere comes the sun--is vitamin D a cure for all that ails us?Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association
P50
Q34219439-360E7150-936D-4ED9-98CF-24102CEAAB63Q35207924-9DA435E1-1F34-47FE-A75A-209613F8359BQ35951296-BB402475-9EB2-4FFD-B10A-A4A427A99C4BQ36199074-CB55F12B-E27C-4528-9459-D864F3DB69B3Q36496692-69EB83B9-BCA6-467F-9C1D-283D93107598Q37181142-87260909-4FB6-4BB1-8F75-2C02695F172EQ37225161-7148B944-327E-4F4F-9C1F-E8CA48990FDAQ38981830-2866786B-FDCB-4E75-BBFB-A6C6D5CA93E2Q39816396-C21259AB-49C5-4410-A209-80A291A2B0A8Q40357609-93E6FBB3-83AD-42E8-AF6C-F04AE5397757Q45050593-52F15D58-09A0-47CB-87DE-9587B3A8CAC0Q47311191-C58B0395-5772-499F-8E3E-93B522A115EFQ51392366-A6393611-5252-41A6-9C19-D3448EF661CEQ84509089-1B77B1A8-F537-4D74-9295-EABE86CA2685Q87058686-C58C36A0-2A8E-49D0-8746-533F64D8DBD0Q87551444-374805E9-571D-411A-B634-EFCA6DF096EA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sheela N Magge
@ast
Sheela N Magge
@en
Sheela N Magge
@es
Sheela N Magge
@nl
type
label
Sheela N Magge
@ast
Sheela N Magge
@en
Sheela N Magge
@es
Sheela N Magge
@nl
prefLabel
Sheela N Magge
@ast
Sheela N Magge
@en
Sheela N Magge
@es
Sheela N Magge
@nl
P106
P1153
6603598114
P31
P496
0000-0002-0949-4399